Indications and uses
for the relief of • Heartburn • Acid Indigestion • Sour Stomach
for the relief of • Heartburn • Acid Indigestion • Sour Stomach
Do not use if outer seal is broken, replace cap tightly Do not exceed daily recommended dosage Shake well & drink 2-4 ounces as symptoms occur Adults and children 12 years and over Up to 4oz. every 4 hours as sumptoms occur or as prescribed by a doctor Do not exceed 16 ounces in 24 hours Adults 60 and over Up to 4oz. every 4 hours as sumptoms occur or as prescribed by a doctor Do not exceed 12 ounces in 24 hou...
Each 4 oz Dose contains: sodium 640mg Each 4 oz Dose contains: potassium 353mg Each 4 oz Dose contains: calcium 218mg Store below 86 degrees F (30 degrees C)
Calcium carbonate USP 545mg
Potassium bicarbonate USP 905mg
Sodium bicarbonate USP 2110mg
Antacid
Antacid
Antacid
for the relief of
• Heartburn • Acid Indigestion • Sour Stomach
•Kidney Disease
•A Potassium or Sodium-Restricted Diet
are currently taking a prescription drug. Antacids may interact with certain prescription drugs.
if you have taken the maximum dose for 2 weeks.
ask a health professional before use.
| Adults and children 12 years and over | Up to 4oz. every 4 hours as sumptoms occur or as prescribed by a doctor | Do not exceed 16 ounces in 24 hours |
| Adults 60 and over | Up to 4oz. every 4 hours as sumptoms occur or as prescribed by a doctor | Do not exceed 12 ounces in 24 hours |
| Children under 12 years | Ask a doctor |
magnesium hydroxide, metyl paraben, natural flavors, propyl paraben, purified water, sucralose
1-888-959-6207 weekdays
reliefotc.com
New!
Fast heartburn Relief
OTC
antacid
great tasting
ORANGE CREME
12 fl. oz. (354 mL)
Fast Heartburn Relief Begins with One Sip!
Heartburn Relief that's Easy to Swallow.
A Great Tasting, Non-Chalky, Clear Liquid
Take RELIEF OTC ANYTIME for
Distributed by
Tummy Company, Inc.
Phoenix,
AZ 85054
2014 Made in the USA
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1538288 | calcium 545 MG / potassium 905 MG / sodium bicaronate 2110 MG in 118 mL Oral Suspension | PSN | 1 |
| 1538294 | Fast Heartburn Relief OTC 545 MG / 905 MG / 2110 MG in 118 mL Oral Suspension | PSN | 1 |
| 1538294 | calcium carbonate 4.62 MG/ML / potassium bicarbonate 7.67 MG/ML / sodium bicarbonate 17.9 MG/ML Oral Suspension [Fast Heartburn Relief OTC] | SBD | 1 |
| 1538288 | calcium carbonate 4.62 MG/ML / potassium bicarbonate 7.67 MG/ML / sodium bicarbonate 17.9 MG/ML Oral Suspension | SCD | 1 |
| 1538288 | calcium 545 MG / potassium 905 MG / sodium bicaronate 2110 MG per 118 ML Oral Suspension | SY | 1 |
| 1538288 | Calcium Carbonate 4.62 MG/ML / K+ bicarbonate 7.67 MG/ML / NaHCO3 17.9 MG/ML Oral Suspension | SY | 1 |
| 1538294 | Calcium Carbonate 4.62 MG/ML / K+ bicarbonate 7.67 MG/ML / NaHCO3 17.9 MG/ML Oral Suspension [Fast Heartburn Relief OTC] | SY | 1 |
| 1538288 | Calcium Carbonate 4.62 MG/ML / Pot bicarbonate 7.67 MG/ML / NaHCO3 17.9 MG/ML Oral Suspension | SY | 1 |
| 1538294 | Calcium Carbonate 4.62 MG/ML / Pot bicarbonate 7.67 MG/ML / NaHCO3 17.9 MG/ML Oral Suspension [Fast Heartburn Relief OTC] | SY | 1 |
| 1538294 | Fast Heartburn Relief OTC (calcium carbonate 545 MG / potassium bicarbonate 905 MG / sodium bicarbonate 2110 MG per 118 ML) Oral Suspension | SY | 1 |
| 1538294 | Fast Heartburn Relief OTC 545 MG / 905 MG / 2110 MG per 118 ML Oral Suspension | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| POTASSIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| SODIUM CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69016-001-18 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4cf2-60a7-e053-dbdaa90a05bd | Relief OTC Antacid |
| 69016-001-54 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4cf2-60a7-e053-dbdaa90a05bd | Relief OTC Antacid |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69016-001-18 | Relief OTC antacid | 118 mL in 1 BOTTLE | LIQUID | 118 | 1 | |
| 69016-001-54 | Relief OTC antacid | 354 mL in 1 BOTTLE | LIQUID | 354 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM CARBONATE | ACTIVE INGREDIENT | H0G9379FGK | 1 | |
| POTASSIUM BICARBONATE | ACTIVE INGREDIENT | HM5Z15LEBN | 1 | |
| SODIUM BICARBONATE | ACTIVE INGREDIENT | 8MDF5V39QO | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| MAGNESIUM HYDROXIDE | INACTIVE INGREDIENT | NBZ3QY004S | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69016-001 | 69016-001-18, 69016-001-54 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM CARBONATE | H0G9379FGK | ACTIM |
| POTASSIUM BICARBONATE | HM5Z15LEBN | ACTIM |
| SODIUM BICARBONATE | 8MDF5V39QO | ACTIB |
| MAGNESIUM HYDROXIDE | NBZ3QY004S | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE, EXTENDED RELEASE / ORAL | 0.22 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 0.4 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | GEL / VAGINAL | 2 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET / ORAL | 45 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SUSPENSION, EXTENDED RELEASE / ORAL | 16 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / NASAL | 140 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | FILM / BUCCAL | 0.22 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRA-ARTICULAR | 0.24 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IONTOPHORESIS | 0.1 %w/v | ||
| MAGNESIUM HYDROXIDE | MAGNESIUM HYDROXIDE | NBZ3QY004S | CAPSULE, DELAYED RELEASE / ORAL | 6.7 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SPRAY, METERED / NASAL | 2 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SUSPENSION / ORAL | 383 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET, CHEWABLE / ORAL | 0.14 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | 30 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SOFT TISSUE | 0.02 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, ORALLY DISINTEGRATING / ORAL | 60 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | 126 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAVENOUS | 95 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | ENEMA / RECTAL | 0.02 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SUBCUTANEOUS | 2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRA-ARTICULAR | 0.03 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / ORAL | 346 mg | ||
| MAGNESIUM HYDROXIDE | MAGNESIUM HYDROXIDE | NBZ3QY004S | TABLET, FILM COATED / ORAL | 43.4 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | 388 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET / ORAL | 1.8 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERINEURAL | 80 mg | ||
| MAGNESIUM HYDROXIDE | MAGNESIUM HYDROXIDE | NBZ3QY004S | POWDER, FOR SUSPENSION / ORAL | 0.01 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / TOPICAL | 216 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM / VAGINAL | 3 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | JELLY / TOPICAL | 180 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IRRIGATION | 2 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 15 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | 30 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERIDURAL | 1 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER / ORAL | NA | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAMUSCULAR | 6 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | GRANULE / ORAL | 5.4 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SOLUTION / INTRAMUSCULAR | 5 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAMUSCULAR | 95 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / PARENTERAL | 2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RECTAL | 0.02 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SYRUP / ORAL | 81 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | FILM / ORAL | 1 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / TOPICAL | 420 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / ORAL | 100 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / VAGINAL | 8 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e6cff231-ba97-4016-ab47-323461fb6d70 | 3b876d55-f199-44cf-8963-7e895b3f5837 | 2014-05-29 | Warnings | e6cff231-ba97-4016-ab47-323461fb6d70 3b876d55-f199-44cf-8963-7e895b3f5837 |
Adverse event summaries are temporarily unavailable. Other product information remains available.